NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis $10.66 -0.20 (-1.80%) As of 12:24 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LifeStance Health Group Stock (NASDAQ:LFST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LFST alerts:Sign Up Key Stats Today's Range$10.63▼$10.8650-Day Range$7.34▼$11.5852-Week Range$3.74▼$11.76Volume551,531 shsAverage Volume3.30 million shsMarket Capitalization$4.14 billionP/E Ratio177.75Dividend YieldN/APrice Target$11.50Consensus RatingModerate Buy Company Overview LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans. The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations. LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services. AI Generated. May Contain Errors. Read More LifeStance Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreLFST MarketRank™: LifeStance Health Group scored higher than 73% of companies evaluated by MarketBeat, and ranked 145th out of 832 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingModerate Buy Consensus RatingLifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageLifeStance Health Group has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LifeStance Health Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth75.00% Earnings GrowthEarnings for LifeStance Health Group are expected to grow by 75.00% in the coming year, from $0.12 to $0.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is 181.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.83.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is 181.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.41.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 2.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.53% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 2.67, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LifeStance Health Group has recently decreased by 1.72%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.96 News SentimentLifeStance Health Group has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for LifeStance Health Group this week, compared to 3 articles on an average week.Search Interest14 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.MarketBeat Follows3 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $63,579,701.00 in company stock.Percentage Held by Insiders3.50% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFST Stock News HeadlinesLifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, BTIG Research Analyst SaysJuly 26, 2026 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Stock Rating Lowered by Wall Street ZenJuly 25, 2026 | americanbankingnews.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.July 30 at 1:00 AM | Paradigm Press (Ad)Canaccord Genuity Group Boosts LifeStance Health Group (NASDAQ:LFST) Price Target to $13.00July 23, 2026 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Recommendation of "Moderate Buy" by AnalystsJuly 22, 2026 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Sets New 12-Month High - Still a Buy?July 19, 2026 | americanbankingnews.comLifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026July 16, 2026 | globenewswire.comLifeStance Health refreshes board with new directorsJuly 7, 2026 | tipranks.comSee More Headlines LFST Stock Analysis - Frequently Asked Questions How have LFST shares performed this year? LifeStance Health Group's stock was trading at $7.04 at the start of the year. Since then, LFST stock has increased by 54.3% and is now trading at $10.86. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its earnings results on Wednesday, May, 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. LifeStance Health Group's quarterly revenue was up 21.2% on a year-over-year basis. Read the conference call transcript. Is LifeStance Health Group doing a stock buyback? LifeStance Health Group's Board of Directors approved a share buyback program on Wednesday, February 25th 2026, which allows the company to buy back $100,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.6% of its shares through open market purchases. Shares buyback programs are often an indication that the company's leadership believes its stock is undervalued. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an IPO on Wednesday, June 9th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's top institutional investors include Everhart Financial Group Inc. (0.03%), Contravisory Investment Management Inc. (0.01%) and Handelsbanken Fonder AB (0.01%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Eric Shuey, Robert Bessler, Danish J Qureshi, David Bourdon, Ann Varanakis, Lisa K Miller, Paula Cipollone and Ujjwal Ramtekkar. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeStance Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/06/2026Today7/30/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (11m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 LFST's financial health is in the Green zone, according to TradeSmith. LFST has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:LFST CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees10,961Year Founded2017Price Target and Rating Average Price Target for LifeStance Health Group$11.50 High Price Target$15.00 Low Price Target$8.00 Potential Upside/Downside+7.7%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio178.42 Forward P/E Ratio88.98 P/E GrowthN/ANet Income$9.66 million Net Margins1.55% Pretax Margin2.25% Return on Equity1.56% Return on Assets1.07% Debt Debt-to-Equity Ratio0.18 Current Ratio1.48 Quick Ratio1.48 Sales & Book Value Annual Sales$1.42 billion Price / Sales2.91 Cash Flow$0.16 per share Price / Cash Flow66.82 Book Value$3.91 per share Price / Book2.73Miscellaneous Outstanding Shares387,830,000Free Float374,260,000Market Cap$4.14 billion OptionableOptionable Beta1.12 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:LFST) was last updated on 7/30/2026 by MarketBeat.com Staff. From Our PartnersCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX just minted 4,400 millionairesSpaceX's $1.75 trillion IPO turned more than 4400 employees into millionaires, according to The New York Times...The Oxford Club | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredElon’s message for AmericaElon Musk bought Super Bowl ad time at $266,000 per second - something he has never done before. 125 million A...Stansberry Research | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredSell SpaceX Now. Buy This Instead.Rob Spivey traveled to SpaceX's Starbase, Texas headquarters to uncover what Wall Street missed in the company...Altimetry | SponsoredBNZI Is Building an AI Growth EngineBanzai International (NASDAQ: BNZI) just earned a Zacks Rank 2 (Buy) upgrade, reflecting rising confidence in ...Huge Alerts | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
